shareholders equity 1,386.50 1,444.30 -57.80 -4% Unit: Million Thai Baht (THB) H1 2019 YTD H1 2018 YTD YoY change YoY % change Cash and cash equivalents at beginning of period 38.85 50.34 -11.49 -23% Net cash
of THB 44mn and dividends paid of THB 11mn. TWELVE-MONTH CASH FLOW SNAPSHOT 195 180 58 55 263 Beginning cash (31-Dec-17) CFO CFI CFF Ending cash (31-Mar-18) 6 MASTER AD PLC MANAGEMENT DISCUSSION
beginning of period 50.34 96.78 -46.44 -47.99% Net cash flows from operating activities 152.69 -21.20 173.89 -820.08% Net cash flows used in investing activities -333.77 -18.60 -315.16 -1694.16% Net cash
, the company had beginning cash and cash equivalents of 37.48 million Baht, whereby during the financial period, net cash was increased by 78.10 million Baht. This comprised of the following items: 1
approximately 4-6 months for customers’ awareness and regular use of service which causes income to reach the Company’s standard. Therefore, depreciation cost rises over an income at the beginning period of kiosk
approximately 4-6 months for customers’ awareness and regular use of service which causes income to reach the Company’s standard. Therefore, depreciation cost rises over an income at the beginning period of kiosk
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
% change Cash and cash equivalents at beginning of period 50.34 96.78 -46.44 -48% Net cash flows from operating activities 27.24 38.48 -11.24 -29% Net cash flows used in investing activities -350.57 -33.35
CASH FLOW SNAPSHOT 195 384 (338) 834 1,073 Beginning cash (31-Dec-17) CFO CFI CFF Ending cash (30-Sep-18) 8 MD&A 3Q 2018 (ended 30 September 2018) MASTER AD PLC MANAGEMENT DISCUSSION & ANALYSIS 3Q 2018 6
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures